CCS Associates is pleased to announce the award of a regulatory affairs support contract for the National Institute on Drug Abuse (NIDA), Division of Therapeutics and Medical Consequences (DTMC), NIH. The purpose of this contract is to provide services and resources to support the Regulatory Affairs branch of NIDA, DTMC. CCS Associates will assist with conversion from paper to electronic filings, expert consultation on regulatory science, and support of regulatory submissions in accordance with FDA regulations, and International Conference Harmonisation and GCP guidelines.

NIDA, DTMC expedites identification, evaluation, development, and approval of compounds and new medications for the treatment of drug abuse and addiction. More information on NIDA can be found here.